日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Telerehabilitation Following Stroke: Development of Training Content and Evaluation of an App-Based Training Program

中风后远程康复:基于应用程序的培训内容开发和评估

Ziller, Carina; Gäumann, Szabina; Lüscher, Silya; Paulissen, Nele; Behrendt, Frank; Suica, Zorica; Crüts, Björn; Gamerschlag, Luana; Parmar, Katrin; Gerth, Hans Ulrich; Bonati, Leo H; Schuster-Amft, Corina

Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

更正:荷兰2型糖尿病相关慢性肾病患者使用非奈利酮的成本效益分析

Quist, Sara W; van Schoonhoven, Alexander V; Bakker, Stephan J L; Pochopień, Michał; Postma, Maarten J; van Loon, Jeanni M T; Paulissen, Jeroen H J

Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy

曲妥珠单抗德鲁替康治疗既往接受过化疗的不可切除或转移性HER2低表达乳腺癌患者的成本效益

Paulissen, Jeroen Hendrikus Jacobus; van Schoonhoven, Alexander Victor; Olin, Emma; Postma, Arjan Jacobus; Mbanya, Zacharie; Dunton, Kyle John; Postma, Maarten Jacobus; van Hulst, Marinus; Freriks, Roel Donald

Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective

抗 VEGF 疗法治疗糖尿病性黄斑水肿:从荷兰社会视角分析更持久疗法的疗效、安全性和成本

Quist, Sara W; Paulissen, Jeroen H J; Lunk, Izabella; Carrasco, Joao; Woudstra, Marrit A; Pochopien, Michal; Nikodem, Mateusz; Crossan, Catriona; Amarakoon, Sankha; van Asten, Freekje; Postma, Maarten J

Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients - A systematic review and Meta-Analysis

成人脑、头颈部和颅底肿瘤患者放射治疗引起的下丘脑-垂体轴功能障碍——系统评价和荟萃分析

Paulissen, J M J; Zegers, C M L; Houben, R M; Hofstede, D; Kars, M; van Santen, H M; Hoebers, F J P; Ruysscher, D K M De; Eekers, D B P

Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials

无论基线改良Mayo评分如何,Mirikizumab治疗中重度活动性溃疡性结肠炎的疗效和安全性:来自3期LUCENT试验的结果

Abraham, Bincy; Wu, Jianmin; Vermeire, Séverine; Melmed, Gil; Ungaro, Ryan; Charabaty, Aline; Moses, Richard; Chan-Diehl, Faye; Paulissen, Jerome; Zhu, Baojin; Barnes, Edward L; Ehrlich, Adam C; Rubin, David T

Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study

托法替尼减量治疗稳定缓解期溃疡性结肠炎患者疗效结果的潜在预测因素:RIVETING 研究结果的事后分析

Torres, Joana; D'Haens, Geert R; Regueiro, Miguel; Santana, Genoile; Panés, Julian; Vermeire, Séverine; Gardiner, Sean; Kulisek, Nicole; Modesto, Irene; Su, Chinyu; Lawendy, Nervin; Mundayat, Rajiv; Paulissen, Jerome; Dubinsky, Marla C

Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspective

从社会角度分析非奈利酮治疗轻度至晚期慢性肾脏病合并2型糖尿病患者的成本效益

Quist, Sara Wilhelmien; van Loon, Jeanni; Bakker, Stephan; Pochopién, Michal; Postma, Maarten J; Paulissen, Jeroen

Mirikizumab impact on disease clearance in patients with moderately to severely active ulcerative colitis: analysis of a pre-specified LUCENT trial endpoint

Mirikizumab 对中重度活动性溃疡性结肠炎患者疾病清除的影响:一项预先设定的 LUCENT 试验终点分析

Colombel, Jean-Frederic; Wu, Jianmin; Kobayashi, Taku; Zhu, Baojin; Paulissen, Jerome; Dhanabal, Agni; Jairath, Vipul; Siegel, Corey; Siegmund, Britta; Redondo, Isabel; Moses, Richard; Magro, Fernando

Central conducting lymphatic anomaly: from bench to bedside

中央传导淋巴管异常:从实验室到临床

Garlisi Torales, Luciana Daniela; Sempowski, Benjamin A; Krikorian, Georgia L; Woodis, Kristina M; Paulissen, Scott M; Smith, Christopher L; Sheppard, Sarah E